These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 27591329

  • 1. Moderator's view: The use of calcineurin inhibitors in the treatment of lupus nephritis.
    Kronbichler A, Neumann I, Mayer G.
    Nephrol Dial Transplant; 2016 Oct; 31(10):1572-6. PubMed ID: 27591329
    [Abstract] [Full Text] [Related]

  • 2. The effect of calcineurin inhibitors in the induction and maintenance treatment of lupus nephritis: a systematic review and meta-analysis.
    Zhang X, Ji L, Yang L, Tang X, Qin W.
    Int Urol Nephrol; 2016 May; 48(5):731-43. PubMed ID: 26781720
    [Abstract] [Full Text] [Related]

  • 3. Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.
    Mok CC.
    Nephrol Dial Transplant; 2016 Oct; 31(10):1561-6. PubMed ID: 27591327
    [Abstract] [Full Text] [Related]

  • 4. Con: The use of calcineurin inhibitors in the treatment of lupus nephritis.
    Fernandez Nieto M, Jayne DR.
    Nephrol Dial Transplant; 2016 Oct; 31(10):1567-71. PubMed ID: 27591328
    [Abstract] [Full Text] [Related]

  • 5. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
    Mok CC, Ying KY, Yim CW, Siu YP, Tong KH, To CH, Ng WL.
    Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
    [Abstract] [Full Text] [Related]

  • 6. Comparative Efficacy and Safety of Tacrolimus, Cyclosporin A, Mycophenolate Mofetil, Cyclophosphamide, and Corticosteroids as Induction Therapy for Membranous Lupus Nephritis: A Network Meta-Analysis.
    Lee YH, Song GG.
    Pharmacology; 2022 Jan; 107(9-10):439-445. PubMed ID: 35609529
    [Abstract] [Full Text] [Related]

  • 7. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis.
    Choi CB, Won S, Bae SC.
    Lupus; 2018 May; 27(6):1007-1011. PubMed ID: 29448881
    [Abstract] [Full Text] [Related]

  • 8. Calcineurin inhibitors in systemic lupus erythematosus.
    Mok CC.
    Best Pract Res Clin Rheumatol; 2017 Jun; 31(3):429-438. PubMed ID: 29224682
    [Abstract] [Full Text] [Related]

  • 9. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial.
    Kamanamool N, Ingsathit A, Rattanasiri S, Ngamjanyaporn P, Kasitanont N, Chawanasuntorapoj R, Pichaiwong W, Anutrakulchai S, Sangthawan P, Ophascharoensuk V, Avihingsanon Y, Sumethkul V.
    Lupus; 2018 Apr; 27(4):647-656. PubMed ID: 29105558
    [Abstract] [Full Text] [Related]

  • 10. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
    Zhu B, Chen N, Lin Y, Ren H, Zhang W, Wang W, Pan X, Yu H.
    Nephrol Dial Transplant; 2007 Jul; 22(7):1933-42. PubMed ID: 17405792
    [Abstract] [Full Text] [Related]

  • 11. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
    Fanouriakis A, Kostopoulou M, Cheema K, Anders HJ, Aringer M, Bajema I, Boletis J, Frangou E, Houssiau FA, Hollis J, Karras A, Marchiori F, Marks SD, Moroni G, Mosca M, Parodis I, Praga M, Schneider M, Smolen JS, Tesar V, Trachana M, van Vollenhoven RF, Voskuyl AE, Teng YKO, van Leew B, Bertsias G, Jayne D, Boumpas DT.
    Ann Rheum Dis; 2020 Jun; 79(6):713-723. PubMed ID: 32220834
    [Abstract] [Full Text] [Related]

  • 12. Multitarget therapy of mycophenolate mofetil and cyclosporine A for induction treatment of refractory lupus nephritis.
    Jesus D, Rodrigues M, da Silva JAP, Inês L.
    Lupus; 2018 Jul; 27(8):1358-1362. PubMed ID: 29448882
    [Abstract] [Full Text] [Related]

  • 13. Outcome and predictors of renal survival in patients with lupus nephritis: Comparison between cyclophosphamide and mycophenolate mofetil.
    Joo YB, Kang YM, Kim HA, Suh CH, Kim TJ, Park YW, Lee J, Lee JH, Yoo DH, Bae SC, Lee HS, Bang SY.
    Int J Rheum Dis; 2018 May; 21(5):1031-1039. PubMed ID: 29611341
    [Abstract] [Full Text] [Related]

  • 14. The Evolving Role of Calcineurin Inhibitors in Treating Lupus Nephritis.
    Peleg Y, Bomback AS, Radhakrishnan J.
    Clin J Am Soc Nephrol; 2020 Jul 01; 15(7):1066-1072. PubMed ID: 32152065
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of cyclophosphamide and non-cyclophosphamide in the induction therapy of Malaysian lupus nephritis patients.
    Rosli FZ, Shaharir SS, Abdul Gafor AH, Mohd R, Aizuddin AN, Osman S.
    Lupus; 2022 Aug 01; 31(9):1138-1146. PubMed ID: 35608373
    [Abstract] [Full Text] [Related]

  • 16. Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis.
    Rathi M, Goyal A, Jaryal A, Sharma A, Gupta PK, Ramachandran R, Kumar V, Kohli HS, Sakhuja V, Jha V, Gupta KL.
    Kidney Int; 2016 Jan 01; 89(1):235-42. PubMed ID: 26489028
    [Abstract] [Full Text] [Related]

  • 17. Addition of cyclosporine/tacrolimus for pediatric relapsed lupus nephritis during mycophenolate mofetil maintenance therapy.
    Mao Y, Yin L, Huang H, Zhou Z, Chen T, Zhou W.
    J Int Med Res; 2019 Jan 01; 47(1):105-113. PubMed ID: 30208769
    [Abstract] [Full Text] [Related]

  • 18. Multitarget therapy versus intravenous cyclophosphamide in the induction treatment of lupus nephritis: a metaanalysis of randomized controlled trials.
    Deng J, Luo L, Zhu L, Xie H, xie H.
    Turk J Med Sci; 2018 Oct 31; 48(5):901-910. PubMed ID: 30384552
    [Abstract] [Full Text] [Related]

  • 19. Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis.
    Mok CC, Ho LY, Ying SKY, Leung MC, To CH, Ng WL.
    Ann Rheum Dis; 2020 Aug 31; 79(8):1070-1076. PubMed ID: 32448782
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy and safety of tacrolimus, mycophenolate mofetil, azathioprine, and cyclophosphamide as maintenance therapy for lupus nephritis : A Bayesian network meta-analysis of randomized controlled trials.
    Lee YH, Song GG.
    Z Rheumatol; 2017 Dec 31; 76(10):904-912. PubMed ID: 27638015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.